SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CABRINI, Giulio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.542
AS - Asia 898
EU - Europa 570
SA - Sud America 173
AF - Africa 15
OC - Oceania 1
Totale 3.199
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.496
SG - Singapore 335
CN - Cina 254
IT - Italia 217
BR - Brasile 147
HK - Hong Kong 116
DE - Germania 87
VN - Vietnam 63
PL - Polonia 51
GB - Regno Unito 42
SE - Svezia 39
ID - Indonesia 37
TR - Turchia 37
FI - Finlandia 29
UA - Ucraina 28
CA - Canada 23
RU - Federazione Russa 23
MX - Messico 20
NL - Olanda 20
JP - Giappone 13
AR - Argentina 12
IN - India 12
FR - Francia 8
BD - Bangladesh 7
ZA - Sudafrica 7
ES - Italia 6
IQ - Iraq 6
BE - Belgio 4
VE - Venezuela 4
CO - Colombia 3
CZ - Repubblica Ceca 3
MA - Marocco 3
UZ - Uzbekistan 3
AT - Austria 2
CH - Svizzera 2
CL - Cile 2
EG - Egitto 2
IR - Iran 2
KR - Corea 2
LT - Lituania 2
LV - Lettonia 2
MK - Macedonia 2
PA - Panama 2
PH - Filippine 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EC - Ecuador 1
IL - Israele 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
Totale 3.199
Salva come PNG Salva come JPEG
Città #
Ashburn 215
Singapore 214
Fairfield 126
Hong Kong 116
Woodbridge 110
Beijing 104
Ferrara 97
Santa Clara 94
Los Angeles 74
Chandler 73
Houston 65
Dallas 56
Warsaw 50
Wilmington 48
Cambridge 46
Seattle 45
Munich 44
Jakarta 35
Ann Arbor 32
Jacksonville 30
New York 25
Shanghai 25
Ho Chi Minh City 21
Izmir 19
Addison 18
Buffalo 17
Princeton 17
Turku 17
São Paulo 16
Hanoi 15
Milan 15
Brooklyn 14
Tokyo 13
Mexico City 12
Chicago 11
Nanjing 11
Washington 11
Denver 10
Boardman 9
London 9
Toronto 9
Ankara 8
Bologna 8
Bremen 8
Shenyang 8
Chennai 7
Dong Ket 7
Montreal 7
Poplar 7
San Jose 7
Stockholm 7
Council Bluffs 6
Frankfurt am Main 6
Moscow 6
Nuremberg 6
Orem 6
Padova 6
Querétaro 6
San Diego 6
Tianjin 6
Amsterdam 5
Hebei 5
Hefei 5
Helsinki 5
Mountain View 5
Rio de Janeiro 5
Assago 4
Atlanta 4
Boston 4
Brasília 4
Changsha 4
Dearborn 4
Ferrara di Monte Baldo 4
Jiaxing 4
Johannesburg 4
Nanchang 4
San Francisco 4
The Dalles 4
Baghdad 3
Brussels 3
Campinas 3
Cape Town 3
Cesena 3
Columbus 3
Da Nang 3
Dhaka 3
Harvard 3
Jinan 3
Lauterbourg 3
Manchester 3
Naples 3
Norwalk 3
Phoenix 3
Redwood City 3
Tashkent 3
Trieste 3
Vancouver 3
Auburn Hills 2
Augusta 2
Bacoli 2
Totale 2.257
Salva come PNG Salva come JPEG
Nome #
Differential Effects of Angelicin Analogues on NF-kB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 233
Mitochondrial Ca2+-dependent NLRP3 activation exacerbates the Pseudomonas aeruginosa-driven inflammatory response in cystic fibrosis 210
An antisense peptide nucleic acid against Pseudomonas aeruginosa inhibiting bacterial-induced inflammatory responses in the cystic fibrosis IB3-1 cellular model system 208
MicroRNA miR-93-5p regulates expression of IL-8 and VEGF in neuroblastoma SK-N-AS cells 200
Exploring the effect of chirality on the therapeutic potential of N-alkyl-deoxyiminosugars: anti-inflammatory response to Pseudomonas aeruginosa infections for application in CF lung disease 200
Anti-inflammatory activity of novel 4,6,4’-trimethylangelicin’s analogues: effects on the NF-kB activity and IL-8 expression in Cystic Fibrosis IB3-1 cells 189
A new method for measuring local ATP release at the extracellular surface of live intact cells 183
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 162
A PNA-based masking strategy for CFTR upregulation by targeting miR-145-5p binding sites of CFTR mRNA 141
A Molecular Signature associated with prolonged survival in Glioblastoma patients treated with Regorafenib 138
A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3’UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells 136
509 Cystic fibrosis transmembrane conductance regulator positively regulates angiotensin-converting enzyme 2 expression and SARS-CoV-2 viral entry into airway epithelial cells: Implications for patients with cystic fibrosis 130
A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1 125
Pharmacological modulation of mitochondrial calcium uniporter controls lung inflammation in cystic fibrosis 115
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 110
SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation 108
Mitochondrial Ca2+-dependent inflammasome activation exacerbates the P. aeruginosa-driven inflammatory response 103
Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene 94
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 91
miRNAs in Serum Exosomes for Differential Diagnosis of Brain Metastases 87
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis 72
Overview of CF lung pathophysiology 71
CFTR Modulators and Reduction of Airway Inflammation in Cystic Fibrosis: How Much is Enough? 68
Revealing the microRNA-transcription factors network in cystic fibrosis:from microRNA therapeutics to precision medicine (CF-miRNA-THER) FFC 7/2018 66
A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients 32
Evaluation of hyaluronic acid derivates as new anti-inflammatory treatments for cystic fibrosis 5
GY971, a new anti-inflammatory agent for the treatment of Cystic Fibrosis lung disease 5
Pre-clinical validation of GY971, a new anti-inflammatory agent targeting Nuclear Factor kappa B (NF-kB) 1
Hyaluronic acid derivates as new potential anti-inflammatory agents for Cystic Fibrosis lung disease 1
GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models 1
Totale 3.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021217 0 0 0 0 0 22 40 29 20 40 34 32
2021/2022191 9 8 18 6 9 8 21 13 13 12 25 49
2022/2023191 21 34 4 19 22 14 25 10 16 1 14 11
2023/2024260 13 20 16 3 64 45 9 21 4 3 6 56
2024/2025731 23 29 74 52 75 52 26 39 96 62 102 101
2025/20261.107 204 67 150 220 311 155 0 0 0 0 0 0
Totale 3.285